Control of extensively drug-resistant Pseudomonas aeruginosa co-harboring metallo-β-lactamase enzymes with oprD gene downregulation

被引:1
|
作者
El-Sherbiny, Gamal M. [1 ]
Basha, Amr Mohamad [2 ]
Mabrouk, Mona, I [2 ]
机构
[1] Al Azhar Univ, Fac Sci Boys, Dept Bot & Microbiol, Cairo, Egypt
[2] Egyptian Drug Author, Dept Microbiol, Natl Org Drug Control & Res, Giza, Egypt
关键词
Combinations; Treatment; XDR- Pseudomonas aeruginosa; Control of (XDR-CR Pseudomonas aeruginosa; SYNERGISTIC ACTIVITIES; COMBINATION; MECHANISMS; COLISTIN; IMIPENEM; RIFAMPICIN; STRAINS;
D O I
10.1016/j.ijmmb.2021.11.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: to study control and treatment of infection with extensive drug-resistant carbapenem-resistant Pseudomonas aeruginosa (XDR-CRPA). Methods: Eleven Pseudomonas aeruginosa (XDR-CRPA) strains used in this study were isolated from a clinical sample, identified, and antibiotics susceptibility recorded in a previous study. Real-time PCR (RT-PCR) was performed to determine the expression level of the OprD gene. Besides, a checkerboard technique was performed to assess the effect of polymyxin-B (PDX), colistin (COL), rifampicin (RIF), imipenem (IPM), and meropenem (MEM) during 2 and 3- dimensional antibiotic combinations. Further, the time-kill study was determined for the most potent combination against four representative strains, log io changes of viable cell counts were expressed as their mean value (+/- SD) values. Results: Molecular analysis by Real-time PCR revealed that the diminished expression level of OprD mRNA was overwhelming to various degrees. The checkerboard method demonstrated that the relevant synergism was achieved in 90.9% of strains for both carbapenem antibiotics during the triple combinations. While an additive effect was noted for all the dual regimen assays. Regarding time-kill experiments, a remarkable bactericidal effect with [99.9% killing rate] was observed toward only one strain whilst a bacteriostatic attitude was proven with >= 95% bacterial eradication against the three remaining strains. Conclusions: These findings underscore the promising implications of these combinations for treatment against XDR-Pseudomonas aeruginosa even they are resistant to carbapenems due to multiple mechanisms of action.
引用
收藏
页码:51 / 56
页数:6
相关论文
共 50 条
  • [21] Extensively drug-resistant Pseudomonas aeruginosa spondylodiscitis aftersevere burn trauma
    Strachinaru, Diana Isabela Costescu
    Verroken, Alexia
    Stoefs, Anke
    Gallez, Jean-Luc
    Merabishvili, Maya
    Pirnay, Jean-Paul
    De Vos, Daniel
    Beynsberger, Marc
    Becker, Charlotte
    Rose, Thomas
    Provinciael, Stefanie
    Spiessens, An
    Vanden Berghe, Emily
    Van Innis, Martine
    Banse, Xavier
    Strachinaru, Mihai
    Vanbrabant, Peter
    Soentjens, Patrick
    ACTA CLINICA BELGICA, 2023, 78 : 27 - 28
  • [22] Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial Tears
    Grossman, Marissa K.
    Rankin, Danielle A.
    Maloney, Meghan
    Stanton, Richard A.
    Gable, Paige
    Stevens, Valerie A.
    Ewing, Thomas
    Saunders, Katharine
    Kogut, Sarah
    Nazarian, Elizabeth
    Bhaurla, Sandeep
    Mephors, Jehan
    Mongillo, Joshua
    Stonehocker, Susan
    Prignano, Jeanette
    Valencia, Nickolas
    Charles, Argentina
    Mcnamara, Kiara
    Fritsch, William A.
    Ruelle, Shannon
    Plucinski, Carrie Ann
    Sosa, Lynn E.
    Ostrowsky, Belinda
    Ham, D. Cal
    Walters, Maroya S.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (01) : 6 - 14
  • [23] First Report of an Extensively Drug-Resistant VIM-2 Metallo-β-Lactamase- Producing Brevundimonas diminuta Clinical Isolate
    Almuzara, Marisa N.
    Barberis, Claudia M.
    Rodriguez, Carlos H.
    Famiglietti, Angela M. R.
    Ramirez, Maria S.
    Vay, Carlos A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (08) : 2830 - 2832
  • [24] Nosocomial outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with aromatherapy
    Mayr, Astrid
    Hinterberger, Guido
    Lorenz, Ingo H.
    Kreidl, Peter
    Mutschlechner, Wolfgang
    Lass-Floerl, Cornelia
    AMERICAN JOURNAL OF INFECTION CONTROL, 2017, 45 (04) : 453 - 455
  • [25] Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-β-lactamase determinants in European hospital
    Lagatolla, C
    Tonin, EA
    Monti-Bragadin, C
    Dolzani, L
    Gombac, F
    Bearzi, C
    Edalucci, E
    Gionechetti, F
    Rossolini, GM
    EMERGING INFECTIOUS DISEASES, 2004, 10 (03) : 535 - 538
  • [26] Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-β-lactamase genes in Taiwan
    Huang, Yu-Tsung
    Chang, Shan-Chwen
    Lauderdale, Tsai-Ling
    Yang, Almira J.
    Wang, Jann-Tay
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 59 (02) : 211 - 216
  • [27] Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase
    Nouér, SA
    Nucci, M
    de-Oliveira, MP
    Pellegrino, FLPC
    Moreira, BM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (09) : 3663 - 3667
  • [28] Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
    Horcajada, Juan P.
    Montero, Milagro
    Oliver, Antonio
    Sorli, Luisa
    Luque, Sonia
    Gomez-Zorrilla, Silvia
    Benito, Natividad
    Grau, Santiago
    CLINICAL MICROBIOLOGY REVIEWS, 2019, 32 (04)
  • [29] Clonal relatedness and plasmid profiling of extensively drug-resistant New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae clinical isolates
    Qamar, Muhammad Usman
    Ejaz, Hasan
    Walsh, Timothy R.
    Shah, Asad Ali
    Al Farraj, Dunia A.
    Alkufeidy, Roua M.
    Alkubaisi, Noorah A.
    Saleem, Sidrah
    Jahan, Shah
    FUTURE MICROBIOLOGY, 2021, 16 (04) : 229 - 240
  • [30] Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients
    C. Peña
    S. Gómez-Zorrilla
    C. Suarez
    M. A. Dominguez
    F. Tubau
    O. Arch
    A. Oliver
    M. Pujol
    J. Ariza
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 2791 - 2797